Dihydropteridinone derivatives, preparation method and use thereof

A kind of technology of tetrahydropyridine and piperidine, applied in the field of medicine

CN108290893BActive Publication Date: 2021-01-05SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD
6 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Publication Date
2021-01-05

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

Disclosed are a dihydro pteridinone derivative represented by formula I, a pharmaceutically acceptable salt, ester, solvate, hydrate, isomer, and isotope compound thereof, any polymorphism or racemate thereof, or a metabolite form thereof, and a mixture thereof. Also disclosed are a preparation method for the dihydro pteridinone derivative, and an application in preparation of drugs for treating diseases related to TLR7.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the field of medicine and relates to a TLR7 agonist, in particular to a dihydropteridone derivative, a preparation method and an application thereof. Background technique

[0002] Toll-like receptors (Toll-like receptors, TLR) are an important class of proteins involved in nonspecific immunity (innate immunity), and are also a bridge connecting nonspecific immunity and specific immunity. TLR is a single transmembrane non-catalytic protein, belonging to the pattern recognition receptor (Pattern recognition receptor, PRR) family, which can quickly respond to pathogens. As one of the TLRs family, TLR7 is mainly expressed in lung, placenta, heart, bone marrow, lymph nodes and other tissues; the cells expressing TLR7 are mainly immune cells, including plasma-like dendritic cells (pDCs), myeloid dendritic cells (mDCs) ), B lymphocytes, macrophages, etc. (especially dendritic cells). TLR7 is mainly activated by viral single-stranded...

Examples

preparation example 1

[0312] Preparation 1: N-(6-amino-2-methylsulfonyl-5-nitropyrimidin-4-yl)-N-(3-(pyrrolidine-1-methyl)benzyl)glycine ethyl ester (intermediate Preparation of body 1)

[0313]

[0314] The first step: the preparation of 3-(pyrrolidine-1-methyl)benzonitrile

[0315] 3-cyanobenzaldehyde (60g, 0.458mol) was added to a three-necked flask, THF (500mL) was added to dissolve, pyrrole and acetic acid were added; ice-water bath was cooled, and NaBH(OAc) was added 3 (145g, 0.687mol), after addition, slowly rise to room temperature and stir overnight (about 20 hours); TLC detects that the reaction is complete, the reaction solution is added to 1.5L water, and NaHCO 3 Solution Adjust the pH value of the aqueous solution to 8-9; add EA (500mL×1, 300mL×2) to extract the aqueous layer, combine the EA, wash with saturated brine, and dry over anhydrous sodium sulfate. Concentration of EA gave the title compound (62 g, yield 73%).

[0316] The second step: the preparation of 3-(pyrrolidine-1...

preparation example 2

[0324]Preparation Example 2: Preparation of 3-(4-amino-2-butoxy-6-oxo-6,7-dihydropteridin-8(5H)-yl)methyl-benzaldehyde (Intermediate 2) :

[0325]

[0326] The first step of preparation of N-(3-cyanobenzyl) glycine ethyl ester

[0327] Add m-cyanobenzaldehyde (80g, 0.61mol) and glycine ethyl ester hydrochloride (94g, 0.67mol) into a 2L three-necked flask, add 1.2L methanol, triethylamine and NaBH 3 CN, stirred at room temperature for 6 hours; TLC detected that the reaction was complete, added 4L of water and EA (1L x 1, 500mL x 2) to the reaction solution to extract the aqueous layer, combined EA, washed with saturated brine, and dried over anhydrous sodium sulfate. Concentration of EA yielded 112 g of the product with a yield of 84%.

[0328] The second step: the preparation of N-(6-amino-2-methylthio-5-nitropyrimidin-4-yl)-N-(3-cyanobenzyl)glycine ethyl ester

[0329] Add (3-cyanobenzyl)glycine ethyl ester and 6-amino-5-nitro-2-methylthio-4-chloropyrimidine into a 2L t...

preparation example 3

[0338] Preparation Example 3: Preparation of 6-chloro-2-methylthio-5-nitropyrimidin-4-amine (Intermediate 3)

[0339]

[0340] The raw material 5-nitro-2-methylthio-4,6-dichloropyrimidine (120g, 0.5mol) was added into a three-necked flask and dissolved in 600mL THF, then triethylamine and ammonia methanol (86mL, 0.6mol) were added, and the The reaction was stirred for 1 hour; TLC detected that the reaction was complete, and the reaction solution was added to 2L of water, filtered with suction, and the filter cake was successively washed with purified water (500mL×2) and petroleum ether (400mL) and dried to obtain 95g of the target product, with a yield of 86%.